A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings.
Fiche du document
2008
- doi: 10.1093/cvr/cvn136
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/cvr/cvn136
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/18511433
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0008-6363
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A4BE811449592
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
illnessCiter ce document
A.R. Pries et al., « A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. », Serveur académique Lausannois, ID : 10.1093/cvr/cvn136
Métriques
Partage / Export
Résumé
Obstructive disease of the large coronary arteries is the prominent cause for angina pectoris. However, angina may also occur in the absence of significant coronary atherosclerosis or coronary artery spasm, especially in women. Myocardial ischaemia in these patients is often associated with abnormalities of the coronary microcirculation and may thus represent a manifestation of coronary microvascular disease (CMD). Elucidation of the role of the microvasculature in the genesis of myocardial ischaemia and cardiac damage-in the presence or absence of obstructive coronary atherosclerosis-will certainly result in more rational diagnostic and therapeutic interventions for patients with ischaemic heart disease. Specifically targeted research based on improved assessment modalities is needed to improve the diagnosis of CMD and to translate current molecular, cellular, and physiological knowledge into new therapeutic options.